A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests

NCT03406117 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

182

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Atopic Dermatitis
Psoriasis

Interventions

DRUG: HAT1
OTHER: Saline Solution

Sponsor

Haus Bioceuticals